Dockside LLC Acquires Shares of 31,014 Sabra Healthcare REIT, Inc. $SBRA

Dockside LLC bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 31,014 shares of the real estate investment trust’s stock, valued at approximately $605,000.

Other hedge funds have also made changes to their positions in the company. Principal Financial Group Inc. increased its position in Sabra Healthcare REIT by 21.6% in the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after acquiring an additional 4,431,897 shares during the period. Lasalle Investment Management Securities LLC purchased a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at approximately $66,938,000. Norges Bank purchased a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at approximately $57,945,000. Balyasny Asset Management L.P. acquired a new position in shares of Sabra Healthcare REIT in the second quarter valued at approximately $49,955,000. Finally, Centersquare Investment Management LLC acquired a new position in shares of Sabra Healthcare REIT in the fourth quarter valued at approximately $50,276,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 0.8%

NASDAQ:SBRA opened at $20.32 on Friday. The stock has a fifty day moving average price of $20.00 and a two-hundred day moving average price of $20.02. The stock has a market capitalization of $5.19 billion, a price-to-earnings ratio of 78.16, a PEG ratio of 1.55 and a beta of 0.64. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). The company had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.Sabra Healthcare REIT’s revenue for the quarter was up 24.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.38 earnings per share. As a group, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.9%. The ex-dividend date is Friday, August 14th. Sabra Healthcare REIT’s dividend payout ratio is presently 461.54%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Citizens Jmp lifted their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 22nd. Truist Financial upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Robert W. Baird lifted their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “neutral” rating in a report on Wednesday, July 22nd. Finally, Barclays began coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price target on the stock. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT has an average rating of “Moderate Buy” and an average target price of $22.25.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.